3lbbass| Warner Pharmaceuticals (688799.SH): Benidipine hydrochloride bulk drug substance obtained approval notice for marketing application

Glonghui May 27 丨 Warner Pharmaceutical Factory (6887993lbbass.SH) Announcement3lbbass, the wholly-owned subsidiary Hunan Warner Pharmaceutical Factory Chiral Drugs Co., Ltd. received the issuance of the certificate from the State Food and Drug Administration3lbbassBenidipine hydrochloride's "Notice of Approval for Marketing Application for Chemical Bulk Drugs" and was publicized on the "Registration Information Disclosure of APIs, Pharmaceutical Excipients and Pharmaceutical Packaging Materials" platform of the Center for Drug Evaluation (CDE) of the State Food Administration. Benidipine hydrochloride belongs to a calcium channel blocker and is mainly used to treat essential hypertension and angina pectoris. Benidipine hydrochloride binds to the DHP binding site of cell membrane potential-dependent calcium channels, inhibiting the influx of calcium ions, thereby dilating coronary arteries and peripheral blood vessels.